IBTA vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

IBTA

42.3
AI Score
VS
PACS Wins

PACS

36.1
AI Score

Investment Advisor Scores

IBTA

42score
Recommendation
HOLD

PACS

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IBTA PACS Winner
Forward P/E 24.6914 15.528 PACS
PEG Ratio 0 1.0347 Tie
Revenue Growth 3.3% 9.1% PACS
Earnings Growth -90.2% 51.6% PACS
Tradestie Score 42.3/100 36.1/100 IBTA
Profit Margin -3.2% 4.9% PACS
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY IBTA

Relative Price Performance (Last 90 Days)

IBTA 1M: +18.7% · 3M: +86.3% PACS 1M: +15.7% · 3M: +1.4%

Current Technical Phase

IBTA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.3% over 20 days), RSI 73

RSI (14): 72.9 · Price: $48.90

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.1 · Price: $47.50

Fundamentals Snapshot

Metric IBTA PACS
Market Cap — —
Forward P/E 26.0 17.4
Trailing P/E — 27.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.2%
Operating Margin 0.0% 0.1%
EPS -0.48 1.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.